Novel Approaches to the Treatment of Cancer

This conference is designed for those with a minimum of 3-5 years industry experience in clinical development research into new anti-cancer agents.

This event will cover: new paradigms for targeted therapies, new anti-cancer agents ~ industry viewpoint, novel approaches to the treatment of breast cancer, melanoma and pancreatic cancer, drug development and precision radiotherapy, European drug development initiatives, market access to novel cancer drugs, regulatory issues in marketing authorisation of anti-cancer products, gene and cell therapies and trial endpoints and developing cancer vaccines.

Speakers: Professor Karol Sikora Chief Medical Officer Cancer Partners UK, David Thurston Professor of Drug Discovery King's College, Dr Tobi Arkenau, Sarah Cannon Research UK, Dr Raz Dewji GSK (invited), Dr Mark Harries Guy's & St Thomas' NHS Trust